Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod
- Posted on June 30, 2026
- By Bing News
- 0 Views
- 1 min read
Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod
French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment. View on euronews
